grisofulvin (Cipla USA Inc.)
Welcome to the PulseAid listing for the grisofulvin drug offered from Cipla USA Inc.. This Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cipla USA Inc. |
| NON-PROPRIETARY NAME: | grisofulvin |
| SUBSTANCE NAME: | GRISEOFULVIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SUSPENSION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-03-06 |
| END MARKETING DATE: | 0000-00-00 |
grisofulvin HUMAN PRESCRIPTION DRUG Details:
| Item Description | grisofulvin from Cipla USA Inc. |
| LABELER NAME: | Cipla USA Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 125(mg/5mL) |
| START MARKETING DATE: | 2017-03-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69097-361_31b4395e-4b5d-494d-b17e-65529ef451ee |
| PRODUCT NDC: | 69097-361 |
| APPLICATION NUMBER: | ANDA065354 |
Other GRISEOFULVIN Pharmaceutical Manufacturers / Labelers:
